Company registration number 11574428 (England and Wales)
DBPHYSIOBRISTOL LTD
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
PAGES FOR FILING WITH REGISTRAR
DBPHYSIOBRISTOL LTD
CONTENTS
Page
Director's report
1
Accountants' report
2
Balance sheet
3
Notes to the financial statements
4 - 6
DBPHYSIOBRISTOL LTD
DIRECTOR'S REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 1 -

The director presents his annual report and financial statements for the year ended 30 September 2024.

Director

The director who held office during the year and up to the date of signature of the financial statements was as follows:

Daniel Brown
Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Daniel Brown
Director
25 June 2025
DBPHYSIOBRISTOL LTD
REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY ACCOUNTS OF DBPHYSIOBRISTOL LTD
- 2 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of DBPhysioBristol Ltd for the year ended 30 September 2024 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/gb/en/member/standards/rules-and-standards/rulebook.html.

This report is made solely to the board of directors of DBPhysioBristol Ltd, as a body, in accordance with the terms of our engagement letter dated. Our work has been undertaken solely to prepare for your approval the financial statements of DBPhysioBristol Ltd and state those matters that we have agreed to state to the board of directors of DBPhysioBristol Ltd, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than DBPhysioBristol Ltd and its board of directors as a body for our work or for this report.

It is your duty to ensure that DBPhysioBristol Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of DBPhysioBristol Ltd. You consider that DBPhysioBristol Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of DBPhysioBristol Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Xeinadin South Wales & West Limited
Edinburgh House
1-5 Bellevue Road
Clevedon
North Somerset
BS21 7NP
25 June 2025
DBPHYSIOBRISTOL LTD
BALANCE SHEET
AS AT
30 SEPTEMBER 2024
30 September 2024
- 3 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
3
396
-
0
Current assets
Debtors
4
681
2,205
Cash at bank and in hand
2,362
-
0
3,043
2,205
Creditors: amounts falling due within one year
5
(14,069)
(1,680)
Net current (liabilities)/assets
(11,026)
525
Total assets less current liabilities
(10,630)
525
Creditors: amounts falling due after more than one year
6
(983)
(1,697)
Net liabilities
(11,613)
(1,172)
Capital and reserves
Called up share capital
7
1
1
Profit and loss reserves
(11,614)
(1,173)
Total equity
(11,613)
(1,172)

For the financial year ended 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 25 June 2025
Daniel Brown
Director
Company registration number 11574428 (England and Wales)
DBPHYSIOBRISTOL LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 4 -
1
Accounting policies
Company information

DBPhysioBristol Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Edinburgh House, 1-5 Bellevue Road, Clevedon, Somerset, Wales, BS21 7NP. 3 Bolton Road, Bristol, BS7 8BW.

 

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% Reducing balance method

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

DBPHYSIOBRISTOL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
1
1
3
Tangible fixed assets
Plant and equipment
£
Cost
At 1 October 2023
-
0
Additions
411
At 30 September 2024
411
Depreciation and impairment
At 1 October 2023
-
0
Depreciation charged in the year
15
At 30 September 2024
15
Carrying amount
At 30 September 2024
396
At 30 September 2023
-
0
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
469
2,205
Other debtors
212
-
0
681
2,205
5
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
1,111
1,320
Other creditors
12,958
360
14,069
1,680
DBPHYSIOBRISTOL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 6 -
6
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
983
1,697
7
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
of £1 each
1
1
1
1
2024-09-302023-10-01falsefalsefalse25 June 2025CCH SoftwareCCH Accounts Production 2025.100Physiotherapy services
Daniel Brown
115744282023-10-012024-09-3011574428bus:Director12023-10-012024-09-30115744282024-09-30115744282023-09-3011574428core:PlantMachinery2024-09-3011574428core:PlantMachinery2023-09-3011574428core:CurrentFinancialInstrumentscore:WithinOneYear2024-09-3011574428core:CurrentFinancialInstrumentscore:WithinOneYear2023-09-3011574428core:Non-currentFinancialInstrumentscore:AfterOneYear2024-09-3011574428core:Non-currentFinancialInstrumentscore:AfterOneYear2023-09-3011574428core:CurrentFinancialInstruments2024-09-3011574428core:CurrentFinancialInstruments2023-09-3011574428core:ShareCapital2024-09-3011574428core:ShareCapital2023-09-3011574428core:RetainedEarningsAccumulatedLosses2024-09-3011574428core:RetainedEarningsAccumulatedLosses2023-09-3011574428core:ShareCapitalOrdinaryShareClass12024-09-3011574428core:ShareCapitalOrdinaryShareClass12023-09-3011574428core:PlantMachinery2023-10-012024-09-30115744282022-10-012023-09-3011574428core:PlantMachinery2023-09-3011574428core:WithinOneYear2024-09-3011574428core:WithinOneYear2023-09-3011574428core:Non-currentFinancialInstruments2024-09-3011574428core:Non-currentFinancialInstruments2023-09-3011574428bus:OrdinaryShareClass12023-10-012024-09-3011574428bus:OrdinaryShareClass12024-09-3011574428bus:OrdinaryShareClass12023-09-3011574428bus:PrivateLimitedCompanyLtd2023-10-012024-09-3011574428bus:SmallCompaniesRegimeForAccounts2023-10-012024-09-3011574428bus:FRS1022023-10-012024-09-3011574428bus:AuditExemptWithAccountantsReport2023-10-012024-09-3011574428bus:FullAccounts2023-10-012024-09-30xbrli:purexbrli:sharesiso4217:GBP